Hyo-Kyung Han

Title: Innovations of Hyo-Kyung Han in Pharmaceutical Development

Introduction

Hyo-Kyung Han is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating inflammatory diseases. With a total of three patents to his name, Han's work is recognized for its potential impact on medical treatments.

Latest Patents

Hyo-Kyung Han's latest patents include a compound that exhibits BLT inhibitory activity and a composition for preventing or treating inflammatory diseases. This invention relates to a novel compound that shows leukotriene B4 receptor 2 (BLT2) inhibitory activity. The pharmaceutical composition derived from this compound is designed to prevent or treat inflammatory diseases. The inventors have identified this novel compound as having an excellent effect on enhancing cancer cell death, inhibiting metastasis and chemotactic mobility, and demonstrating anti-asthma activity. Therefore, this compound can serve as a highly effective pharmaceutical component for treating inflammatory-related diseases.

Career Highlights

Throughout his career, Hyo-Kyung Han has worked with esteemed institutions such as Dongguk University Industry-Academic Cooperation Foundation and Korea University Research and Business Foundation. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Hyo-Kyung Han has collaborated with notable colleagues, including Yongseok Choi and Jae-Hong Kim. These partnerships have facilitated the development of innovative solutions in the pharmaceutical field.

Conclusion

Hyo-Kyung Han's contributions to pharmaceutical innovations, particularly in the area of inflammatory disease treatment, highlight his role as a significant inventor. His work continues to pave the way for advancements in medical science.